Obesity

SEP 11, 2026 · PHASE 2 TRIAL

A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

ClinicalTrials.gov

Phase 2 registry record with completed enrollment but no results posted; insufficient to assess efficacy or safety, only study design and conduct are known.

SEP 11, 2026 · INTERVENTIONAL STUDY

Cities for Better Health Childhood Obesity Prevention Initiative

ClinicalTrials.gov

This is a study registration for an ongoing community-based intervention trial with no results reported; enrollment is active and follow-up data collection is not yet complete.

SEP 11, 2026 · PHASE EARLY PHASE 1 TRIAL

Tirzepatide in Obesity-Driven Endometrial Cancer

ClinicalTrials.gov

This is an early-phase, uncontrolled window-of-opportunity study with a planned sample of 20 patients examining a mechanistic hypothesis in a pre-operative setting; no results are yet reported.

SEP 11, 2026 · INTERVENTIONAL STUDY

MagDI Australia Study

ClinicalTrials.gov

Registry record of a completed single-arm feasibility study in a small population (n=25) evaluating a novel device; no results are posted, and the primary focus is procedural feasibility and safety rather than clinical efficacy.

SEP 10, 2026 · PHASE 1 TRIAL

A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet

ClinicalTrials.gov

Phase 1 interventional study with no reported results; registry record describes planned enrollment and design only, insufficient to assess efficacy or safety outcomes.

SEP 10, 2026 · INTERVENTIONAL STUDY

Effects of VLCKD in Metabolic Syndrome

ClinicalTrials.gov

This is a clinical trial registry record with no reported results; enrollment is active but not recruiting, making this an ongoing or recently completed study with outcomes not yet posted to the registry.

SEP 10, 2026 · PHASE 1/2 TRIAL

A Three-part First-in-human Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB-UCN2 in Healthy Lean and Obese Participants and Participants With T2D

ClinicalTrials.gov

This is a first-in-human Phase 1/2 trial registration with no results reported; the record describes planned enrollment and safety endpoints only.

SEP 10, 2026 · OBSERVATIONAL STUDY

Susceptibility to Infectious Diseases in Obesity

ClinicalTrials.gov

This is a clinical trial registry record describing a planned observational study with no results posted; it represents early-phase hypothesis-generating work examining associations between microbiota, immunity, and infection susceptibility in obesity.